Genesis Healthcare (GEN) Stock Price Up 6.6%

Genesis Healthcare Inc (NYSE:GEN) shares rose 6.6% during trading on Thursday . The stock traded as high as $2.44 and last traded at $2.59. Approximately 36,434 shares traded hands during trading, a decline of 95% from the average daily volume of 704,384 shares. The stock had previously closed at $2.43.

GEN has been the subject of several analyst reports. Stifel Nicolaus set a $2.00 price target on shares of Genesis Healthcare and gave the stock a “hold” rating in a report on Tuesday, April 24th. ValuEngine cut shares of Genesis Healthcare from a “buy” rating to a “hold” rating in a report on Monday, April 2nd. Finally, Stephens reiterated a “hold” rating and set a $2.00 price target on shares of Genesis Healthcare in a report on Monday, March 19th. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. Genesis Healthcare presently has a consensus rating of “Hold” and a consensus price target of $2.00.

The company has a debt-to-equity ratio of -2.80, a quick ratio of 1.11 and a current ratio of 1.11. The firm has a market capitalization of $366.72 million, a P/E ratio of -1.23 and a beta of 1.00.

Genesis Healthcare (NYSE:GEN) last posted its quarterly earnings results on Thursday, May 10th. The company reported ($0.70) EPS for the quarter, missing the consensus estimate of ($0.36) by ($0.34). The business had revenue of $1.30 billion for the quarter, compared to the consensus estimate of $1.32 billion. During the same period in the previous year, the business earned ($0.55) EPS. research analysts expect that Genesis Healthcare Inc will post -1.32 earnings per share for the current year.

Several institutional investors have recently modified their holdings of the company. V3 Capital Management L.P. boosted its holdings in shares of Genesis Healthcare by 2.0% in the 4th quarter. V3 Capital Management L.P. now owns 2,261,899 shares of the company’s stock valued at $1,726,000 after buying an additional 44,500 shares in the last quarter. BSW Wealth Partners boosted its holdings in shares of Genesis Healthcare by 74.2% in the 1st quarter. BSW Wealth Partners now owns 115,000 shares of the company’s stock valued at $174,000 after buying an additional 49,000 shares in the last quarter. California Public Employees Retirement System boosted its holdings in shares of Genesis Healthcare by 23.3% in the 1st quarter. California Public Employees Retirement System now owns 309,910 shares of the company’s stock valued at $468,000 after buying an additional 58,610 shares in the last quarter. Millennium Management LLC boosted its holdings in shares of Genesis Healthcare by 40.6% in the 1st quarter. Millennium Management LLC now owns 338,678 shares of the company’s stock valued at $511,000 after buying an additional 97,834 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. acquired a new position in shares of Genesis Healthcare in the 1st quarter valued at $153,000. Institutional investors and hedge funds own 18.70% of the company’s stock.

Genesis Healthcare Company Profile

Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.

Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply